American Society of Hirudotherapy

Penile Replantation: A Review of Microsurgical Techniques, Patient Outcomes, and Solutions to Complex Reconstructive Challenges

Arbel EJ, Reese AD, Richards R, Singh S, O'Shea AW, Hennig F, Abramowitz D (2024) · Plastic Surgery (Oakville) · n=46

Review: FDA has cleared Hirudo medicinalis as a medical device (K040187, June 21 2004) for venous congestion in surgical flaps. Other uses are off-label or investigational.Study record: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.

Study Profile

Design
comprehensive review of 46 penile replantation cases across 37 studies (PubMed/EMBASE/Cochrane 2015-2023)
Pooled sample (n; included studies may overlap)
46
Scope
Microsurgical penile replantation with various adjuncts including hyperbaric oxygen, laser angiography, leech therapy, PDE inhibitors, and penile splints
Main result
Postoperative necrosis in 56.5% (26/46) of cases; scrotal hematoma in 3 cases; psychiatric comorbidity in 23/46; common adjuncts include hyperbaric O2, laser angiography, leech therapy, PDE inhibitors, and penile splints

Key Findings

  • 46 cases across 37 studies (2015-2023 window)
  • 56.5% postoperative necrosis rate - dominant complication
  • Psychiatric comorbidity in 50% of cases
  • Leech therapy named among innovative adjunct strategies
  • Need for standardized protocols emphasized

Limitations

  • Review of heterogeneous case reports
  • Cannot establish causality of any specific intervention
  • Publication bias toward successful cases
  • Variable outcome reporting across included studies
  • Limited long-term functional follow-up

Clinical Implications

Arbel 2024 contextualizes leech therapy as one of several innovative adjuncts in penile microsurgical replantation. For US clinicians under K040187, the review reinforces leech utility for venous congestion in a population where 56.5% experience postoperative necrosis. The systematic nature provides epidemiological framing for individual case decisions in this rare urologic emergency.

Related studies

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.